Back

Contrast-induced nephropathy after staged balloon pulmonary angioplasty: lower risk compared with left-sided cardiac procedures

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Pulmonary circulation, pulmonary embolism, right heart failure e-posters Intervention ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Ana Rita Pereira

Hospital Garcia de Orta, Almada (Portugal)

73 More presentations in this session

Presentation thumbnail
The novel noninvasive method for prediction of long-term specific therapy efficacy in patients with IPAH and inoperable CTEPH
Mrs I. Lyapina (Kemerovo, RU)
Abstract Slides
Presentation thumbnail
Early and long term prognostic accuracy of 4 acute pulmonary embolism mortality risk scores
Doctor L. Oliveira (Ponta Delgada, PT)
Abstract Slides
Presentation thumbnail
Novel genetic and molecular pathways in pulmonary arterial hypertension associated with connective tissue disease
Doctor I. Hernandez Gonzalez (Valladolid, ES)
Abstract Slides
Presentation thumbnail
Role of echocardiography to avoid misclassification of pulmonary hypertension associated with left heart disease as precapillary pulmonary hypertension.
Assistant Professor J. Grignola Rial (Montevideo, UY)
Abstract Slides
Presentation thumbnail
Survival of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension listed for lung transplantation
Doctor I. Magnani (Bologna, IT)
Abstract

Access the full session

Session thumbnail
Pulmonary circulation, pulmonary embolism, right heart failure e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Contrast-induced nephropathy following PCI: can we calculate a safe contrast volume?
26 August 2022
thumbnail
Congress Presentation
Balloon pulmonary angioplasty for patients with symptomatic chronic thromboembolic disease without pulmonary hypertension
3 September 2019
thumbnail
Congress Presentation
Chronic kidney disease impact after mitraclip therapy: five-year outcomes from the GRASP registry
1 July 2021
thumbnail
Congress Presentation
Feasibility of ultra-low volume contrast pulmonary arterial injection protocol for CTA in TAVI candidates with severe renal failure
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources